PlainVisa
2026 data Public-data reference Official source

Corixa Corporation d/b/a GlaxoSmithKline Vaccines

A DOL Labor Condition Application record spanning FY2023–2025. Review the filing volume, DOL certification record, and offered-wage context below.

View top job titles → How we source this
DOL LCA filings
2
DOL-certified
100%
Median offered wage
$89,024

Marietta, PA NAICS: 325412

Corixa Corporation d/b/a GlaxoSmithKline Vaccines's H-1B LCA filing count

U.S. Department of Labor's OFLC discloses 2 Labor Condition Application filings naming Corixa Corporation d/b/a GlaxoSmithKline Vaccines from FY2023 through FY2025, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

Corixa Corporation d/b/a GlaxoSmithKline Vaccines's USCIS petition outcomes

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 65 H-1B petitions naming Corixa Corporation d/b/a GlaxoSmithKline Vaccines through FY2023, and approved nearly every one of them: 100% approved (65 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Corixa Corporation d/b/a GlaxoSmithKline Vaccines is listed in 2 DOL LCA filings, more filings than 57% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $89,024. This is not a USCIS approval, hiring, or sponsorship ranking.

2
DOL LCA filings, FY2023–FY2025
100%
DOL-certified
$89,024
median offered wage
Top 43%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2025). Based in Marietta, PA.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Corixa Corporation d/b/a GlaxoSmithKline Vaccines vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

2 76945th of 122824 higher than 45,879 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2025

LCA filing shape · Corixa Corporation d/b/a GlaxoSmithKline Vaccin…

Derived from this employer's disclosed LCAs on file (FY2023–FY2025), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $89,024–$89,024 .

Title concentration

  • Project Lead 2 · 100% · $89,024

Worksite counties

  • CAMBRIDGE CITY, MA 2 · 100%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • Corixa Corporation d/b/a GlaxoSmithKline Vaccines's disclosed H-1B LCA filing count rose from 11 in FY2024 to 14 in FY2025 (+27.3%).
  • Corixa Corporation d/b/a GlaxoSmithKline Vaccines's average disclosed H-1B offered wage fell from $160,999 in FY2024 to $113,565 in FY2025 (-29.5%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

Cambridge City, MA worksite concentration

Only 2 LCAs on file for Corixa Corporation d/b/a GlaxoSmithKline Vaccin…, and 100% land in CAMBRIDGE CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 100%.

Certification Rate

100%

Very high DOL cert

Avg. Salary

$89,024

Below portal avg

Total Workers

2

Small worker count

Wage vs. DOL Minimum

+0%

At/above DOL floor

national avg +17.8%

Typical DOL Wage Level

Experienced (Level III)

100% of LCA filings

Full-Time Positions

100%

Primary Worksite County

CAMBRIDGE CITY, MA

100% of LCA filings

Recent LCA Filings

Latest H-1B labor condition applications filed by Corixa Corporation d/b/a GlaxoSmithKline Vaccines

Job Title Location Salary Status Year
Project Lead Cambridge, MA $89,024 Certified - Withdrawn FY2025
Project Lead Cambridge, MA $89,024 Certified FY2023

Nationwide peers near Corixa Corporation d/b/a GlaxoSmithKline Vaccin…'s 2-LCA band

Cross-state DOL neighbors for Corixa Corporation d/b/a GlaxoSmithKline Vaccines - LCA filing-count and offered-wage axes, outside PA.

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($89,024 here).

University of Wisconsin-Milwaukee $89,025 WI Silicon Valley International School $89,022 CA Robert A.M. Stern Architects $89,018 NY Slesha IT Inc $89,044 TX

Disclaimer: Informational only, not professional advice.

Read with Corixa Corporation d/b/a GlaxoSmithKline Vaccin…

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-BELOW.

02 Trucking LLC · TRACE-BOOK

ABS(total_petitions) peer at 2 LCAs (Δ 0 heavier vs Corixa Corporation d/b/a GlaxoSmithKline Vaccin…); CERT-LOCK · WAGE-ELITE vs this page's TRACE-BOOK · CERT-LOCK · WAGE-BELOW.
1 Cochran Buick GMC, Inc. · TRACE-BOOK

ABS(total_petitions) peer at 2 LCAs (Δ 0 heavier vs Corixa Corporation d/b/a GlaxoSmithKline Vaccin…); CERT-LOCK · WAGE-ELITE vs this page's TRACE-BOOK · CERT-LOCK · WAGE-BELOW.
1 Enterprise EOR Services Inc. · TRACE-BOOK

ABS(total_petitions) peer at 2 LCAs (Δ 0 heavier vs Corixa Corporation d/b/a GlaxoSmithKline Vaccin…); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-BELOW.
1 to 1 Therapies INC. · TRACE-BOOK

ABS(total_petitions) peer at 2 LCAs (Δ 0 heavier vs Corixa Corporation d/b/a GlaxoSmithKline Vaccin…); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-BELOW.
Deloitte Consulting LLP · LARGEST-distance pole

PA pole at 13,463 LCAs stamps MEGA-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Corixa Corporation d/b/a GlaxoSmithKline Vaccin…'s TRACE-BOOK.
PA worksite board · TRACE-BOOK

Open the PA state board after the ABS peers. Corixa Corporation d/b/a GlaxoSmithKline Vaccin… stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
Wage levels primer · WAGE-BELOW

Corixa Corporation d/b/a GlaxoSmithKline Vaccin…'s WAGE-BELOW · TRACE-BOOK stamps sit mid-band. Wage levels I-IV explain the floor behind the offer.

What to do with this profile

Use the DOL LCA record for Corixa Corporation d/b/a GlaxoSmithKline Vaccines to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.